BioLife Solutions Inc (BLFS)
Debt-to-equity ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 18,311 | 23,793 | 6,353 | 655 | — |
| Total stockholders’ equity | US$ in thousands | 337,663 | 364,188 | 478,047 | 204,429 | 43,321 |
| Debt-to-equity ratio | 0.05 | 0.07 | 0.01 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $18,311K ÷ $337,663K
= 0.05
BioLife Solutions Inc's debt-to-equity ratio has exhibited an increasing trend over the past five years, starting at 0.00 in 2019 and reaching 0.05 in 2023. This indicates that the company has been gradually taking on more debt relative to its equity during this period.
The sharp increase from 0.00 in 2019 to 0.01 in 2021 suggests a significant change in the company's capital structure, possibly due to funding requirements for expansion or other strategic initiatives. The subsequent rise to 0.07 in 2022 and then a slight decrease to 0.05 in 2023 indicate fluctuations in the company's debt and equity levels relative to each other.
Overall, a debt-to-equity ratio of 0.05 in 2023 implies that BioLife Solutions Inc is utilizing a moderate amount of debt to finance its operations compared to its equity. It is essential for investors and stakeholders to monitor this ratio to assess the company's financial leverage and risk profile in the future.
Peer comparison
Dec 31, 2023